Publicaciones en colaboración con investigadores/as de Universidad Miguel Hernández de Elche (16)

2024

  1. Executive Summary of the Spanish Guidelines for the Diagnosis and Management of Imported Febrile Illnesses from the Spanish Society of Tropical Medicine and International Health (SEMTSI), the Imported Pathology Group of the Spanish Society of Infectious Diseases and Clinical Microbiology (GEPI-SEIMC), the Spanish Society of Family and Community Medicine (SEMFYC), the Spanish Society of Primary Care Physicians (SEMERGEN) and the Spanish Society of Emergency Medicine (SEMES)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 7, pp. 380-385

2023

  1. Consensus on post COVID in the Spanish national health system: Results of the CIBERPOSTCOVID eDelphi study

    Journal of Infection and Public Health, Vol. 16, Núm. 11, pp. 1784-1792

  2. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 7, pp. 1658-1666

2022

  1. Clinical Features and Risk Factors for Mortality Among Long-term Care Facility Residents Hospitalized Due to COVID-19 in Spain

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 77, Núm. 4, pp. E138-E147

  2. Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights

    Trials, Vol. 23, Núm. 1

2021

  1. Clinical Characteristics and Risk Factors for Mortality in Very Old Patients Hospitalized With COVID-19 in Spain

    The journals of gerontology. Series A, Biological sciences and medical sciences, Vol. 76, Núm. 3, pp. e28-e37

  2. Imported leptospirosis in travellers and migrants in Spain: a study of the +REDIVI collaborative network

    Journal of travel medicine, Vol. 28, Núm. 6

2020

  1. La Estadística en la investigación en ciencias de la salud

    BEIO, Boletín de Estadística e Investigación Operativa, Vol. 36, Núm. 3, pp. 293-303

2017

  1. Contribution of Oxidative Stress to Non-AIDS Events in HIV-Infected Patients

    Journal of Acquired Immune Deficiency Syndromes, Vol. 75, Núm. 2, pp. e36-e44

  2. Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach

    PLoS ONE, Vol. 12, Núm. 9

2015

  1. Virological failure to raltegravir in Spain: Incidence, prevalence and clinical consequences

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 11, pp. 3087-3095

2009

  1. Infección por virus de la inmunodeficiencia humana en inmigrantes en España: características epidemiológicas y presentación clínica en la cohorte CoRIS, 2004-2006

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 27, Núm. 7, pp. 380-388

2008

  1. Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status

    International Journal of Tuberculosis and Lung Disease, Vol. 12, Núm. 12, pp. 1393-1400

2007

  1. Progression to AIDS and death and response to HAART in men and women from a multicenter hospital-based cohort

    Journal of Women's Health, Vol. 16, Núm. 7, pp. 1052-1061

2006

  1. Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: Long-term follow-up of a multicenter cohort

    PLoS ONE, Vol. 1, Núm. 1

  2. Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain

    AIDS Research and Human Retroviruses, Vol. 22, Núm. 8, pp. 715-723